BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1308794)

  • 21. Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
    Petru E; Schmähl D
    Neoplasma; 1991; 38(2):147-55. PubMed ID: 2041574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
    Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D
    Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
    Lira P; Grebe G
    Rev Med Chil; 1984 Oct; 112(10):1021-5. PubMed ID: 6085597
    [No Abstract]   [Full Text] [Related]  

  • 24. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Secondary malignant tumors following treatment of Hodgkin's disease].
    Shishkin IP
    Med Radiol (Mosk); 1984 Aug; 29(8):24-8. PubMed ID: 6590941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
    Longo DL; DeVita VT
    Important Adv Oncol; 1992; ():155-65. PubMed ID: 1582671
    [No Abstract]   [Full Text] [Related]  

  • 27. Second malignancy complicating Hodgkin's disease.
    Tawil E; Mercier JP
    J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
    Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Second tumors in patients treated for Hodgkin's disease].
    España P; Bonilla F; Yebra M; Diego J; Alvarez de Mon M; Marazuela M; Durántez A
    Rev Clin Esp; 1988 Apr; 182(6):304-6. PubMed ID: 3406475
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cured from Hodgkin's disease].
    Brice P
    Bull Cancer; 2002; 89(7-8):666-70. PubMed ID: 12206979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-stage Hodgkin's disease: current approaches to treatment.
    Rusthoven JJ; MacKenzie R
    Can Med Assoc J; 1985 Aug; 133(3):193-8. PubMed ID: 3893668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program.
    Klimo P; Connors JM
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):34-40. PubMed ID: 2456621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current management of Hodgkin's disease.
    Behrens BC; Young RC; DeVita VT
    Drugs; 1985 Oct; 30(4):355-67. PubMed ID: 3905335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of MOPP chemotherapy in early stage Hodgkin's disease.
    Mauch P; Hellman S
    Hematol Oncol; 1984; 2(1):66-9. PubMed ID: 6376318
    [No Abstract]   [Full Text] [Related]  

  • 37. The intergroup Hodgkin's disease in children. A study of stages I and II.
    Gehan EA; Sullivan MP; Fuller LM; Johnston J; Kennedy P; Fryer C; Gilchrist GS; Hays DM; Hanson W; Heller R
    Cancer; 1990 Mar; 65(6):1429-37. PubMed ID: 2407336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningioma-like cerebral relapse of Hodgkin's disease.
    Montillo M; Scarpelli M; Discepoli G; Catarini M; Rychlicki F; Leoni P
    Leuk Lymphoma; 1994 Jun; 14(1-2):185-7. PubMed ID: 7920227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematologic neoplasia in patients treated for Hodgkin's disease.
    Coleman CN; Williams CJ; Flint A; Glatstein EJ; Rosenberg SA; Kaplan HS
    N Engl J Med; 1977 Dec; 297(23):1249-52. PubMed ID: 917069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
    Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
    J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.